Skip to content
Search

Latest Stories

Over 100 medicines are currently in short supply, warns BGMA

Over 100 medicines are currently in short supply, warns BGMA

Reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK, ABPI has suggested.  

The British Generic Manufacturers Association (BGMA) on Monday alerted the Health and Social Care Committee that medicines shortages have increased and are “around double what they were a year ago.”


BGMA chief executive Mark Samuels told the committee that they have been highlighting the medicine shortage risk to ministers since July 2021 and the association is “very concerned” about the current situation.

"We've been monitoring it for several years now, and as you saw in the written evidence, shortages have increased. They're around double what they were a year ago. We have them at 101 shortages in February this year,” said Samuels.

Dr Rick Greville, director of distribution and supply at the Association of the British Pharmaceutical Industry (ABPI), highlighted that the problem of drug shortages in the UK is a “long-standing issue" and the scarcity of certain medications "continues to be challenging".

Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies - AIMp, also raised concerns that community pharmacists in the UK are experiencing a “record number of medicines shortages,” and they spend long hours in the day trying to source medicines for patients.

She added that pharmacy teams see firsthand the anxiety and stress experienced by patients due to  medicine shortages.

Navin Khosla, Pharmacist at NowPatient, indicated that Brexit is mainly responsible for the drug shortage issue in the UK, citing reports from several news outlets.

Concerns were also raised about the potential harm of medication shortages in people with diabetes.

Last month, NHS England and the Department of Health and Social Care (DHSC) published a National Patient Safety Alert concerning the shortage of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used to manage blood glucose levels in people with type 2 diabetes.

As per the alert, the supply of the drugs was not expected to return to normal “until at least the end of 2024”.

Helen Kirrane, head of policy, campaigns and mobilisation at Diabetes UK, informed the committee that the shortage of GLP-1 has significantly affected individuals with type 2 diabetes in the past six to eight months.

She expressed that the serious consequences often only become apparent over time, and there is  “serious concern about the harm that could be caused”.

Kirrane added that GLP-1 shortages have resulted in a “huge explosion of interest in this type of medication for weight loss globally over the last year or so” and the charity has seen a “huge surge” in off-label prescribing in the private sector.

To solve the drug shortage issue, Samuels suggested that staff at the Medicines and Healthcare products Regulatory Agency should be retained, as there is a “huge backlog” in the licensing of generic medicines.

Pharmacists should be empowered to make substitutions for alternative appropriate medication or formularies, suggested Janet Morrison, chief executive of Community Pharmacy England (CPE).

According to Dr Greville, reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK.

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less